PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Meta-Research Innovation Center at Stanford (METRICS), Stanford University, 1265 Welch Rd Palo Alto, Stanford, CA, 94305, USA. noahhaber@stanford.edu.\', \'Meta-Research Innovation Center at Stanford (METRICS), Stanford University, 1265 Welch Rd Palo Alto, Stanford, CA, 94305, USA.\', \'Department of Global Health, Milken Institute School of Public Health, George Washington University, 950 New Hampshire Avenue, Washington, DC, 20052, USA.\', \'Centre for Evidence Based Medicine, University of Oxford, Radcliffe Primary Care Building, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-021-05755-y
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 34743755
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Much ado about something: a response to \'COVID-19: underpowered randomised trials, or no randomised trials?\'
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all